MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-204

  1. 11,800 Posts.
    lightbulb Created with Sketch. 750
    I would say they have not finalised talks with Novartis yet so we have not heard anything corporate for now.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.